Literature DB >> 23828296

IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant?

Karin Pelka1, Eicke Latz.   

Abstract

Interferon (IFN) regulatory factors (IRFs) are transcription factors with versatile functions in the regulation of innate and adaptive immune responses. In the current issue of the European Journal of Immunology, Steinhagen et al. [Eur. J. Immunol. 2013. 43: 1896-1906] investigate the regulation of IFN-β and IL-6 induction in human plasmacytoid DCs stimulated with CpG DNA. Using RNA interference studies, the authors identify critical roles for IRF5 and IRF8 as positive and negative regulators, respectively. In contrast, knockdown of IRF7 had no significant effect on IFN-β or IL-6 gene induction. In this Commentary, these findings are discussed in the context of the published literature and recent data regarding IRF5 and IRF8 as susceptibility genes for autoimmunity.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  IRF; Innate immunity; Interferon; pDC

Mesh:

Substances:

Year:  2013        PMID: 23828296     DOI: 10.1002/eji.201343739

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  An oligodeoxynucleotide with AAAG repeats significantly attenuates burn-induced systemic inflammatory responses via inhibiting interferon regulatory factor 5 pathway.

Authors:  Yue Xiao; Wenting Lu; Xin Li; Peiyan Zhao; Yun Yao; Xiaohong Wang; Ying Wang; Zhipeng Lin; Yongli Yu; Shucheng Hua; Liying Wang
Journal:  Mol Med       Date:  2017-06-14       Impact factor: 6.354

2.  Cellular FLIP long isoform (cFLIPL)-IKKα interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFNα expression.

Authors:  Lauren T Gates-Tanzer; Joanna L Shisler
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

Review 3.  Female predisposition to TLR7-driven autoimmunity: gene dosage and the escape from X chromosome inactivation.

Authors:  Mélanie Souyris; José E Mejía; Julie Chaumeil; Jean-Charles Guéry
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

4.  Human plasmacytoid dentritic cells elicit a Type I Interferon response by sensing DNA via the cGAS-STING signaling pathway.

Authors:  Christian Bode; Mario Fox; Poonam Tewary; Almut Steinhagen; Richard K Ellerkmann; Dennis Klinman; Georg Baumgarten; Veit Hornung; Folkert Steinhagen
Journal:  Eur J Immunol       Date:  2016-05-27       Impact factor: 5.532

5.  B Cell-Intrinsic Role for IRF5 in TLR9/BCR-Induced Human B Cell Activation, Proliferation, and Plasmablast Differentiation.

Authors:  Saurav De; Baohong Zhang; Tiffany Shih; Sukhwinder Singh; Aaron Winkler; Robert Donnelly; Betsy J Barnes
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

Review 6.  Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions.

Authors:  Philippe Saas; Alexis Varin; Sylvain Perruche; Adam Ceroi
Journal:  F1000Res       Date:  2017-04-10

Review 7.  Estrogen Receptor-Dependent Regulation of Dendritic Cell Development and Function.

Authors:  Sophie Laffont; Cyril Seillet; Jean-Charles Guéry
Journal:  Front Immunol       Date:  2017-02-10       Impact factor: 7.561

Review 8.  Disease-Associated Plasmacytoid Dendritic Cells.

Authors:  Shuang Li; Jing Wu; Shan Zhu; Yong-Jun Liu; Jingtao Chen
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

Review 9.  Immunological Processes Driving IgE Sensitisation and Disease Development in Males and Females.

Authors:  Jonatan Leffler; Philip A Stumbles; Deborah H Strickland
Journal:  Int J Mol Sci       Date:  2018-05-23       Impact factor: 5.923

10.  Differential and Overlapping Immune Programs Regulated by IRF3 and IRF5 in Plasmacytoid Dendritic Cells.

Authors:  Kwan T Chow; Courtney Wilkins; Miwako Narita; Richard Green; Megan Knoll; Yueh-Ming Loo; Michael Gale
Journal:  J Immunol       Date:  2018-10-08       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.